NORAKER
Company

Last deal

$2.8M
Local Amount - EUR 2.5M

Amount

Grant

Stage

01.12.2019

Date

1

all rounds

$2.8M

Total amount

General

About Company
NORAKER produces implantable medical devices for bone substitution and osteosynthesis.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2005

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

The company designs, produces, and markets synthetic and bioactive biomaterial-based implantable medical devices to improve patient comfort. NORAKER collaborates closely with health professionals to meet market demands and differentiate itself through innovation, using bioactive glass and active ceramic second generation in its device design. Its biomaterial-based implant helps preserve bone quality, and the company offers injectable putty, synthetic and bioactive bone graft substitutes, and resorbable bilayer synthetic membranes to improve the quality of care and patient health.
Contacts